Estados Unidos · Plataformas y datos · Stocktwits

IBRX Stock Rises Overnight: Jim Cramer Backs ImmunityBio As A ‘Very Good Spec’ Amid Biotech Takeover Wave

Publicado por Stocktwits · Estados Unidos hace 12 h

ImmunityBio (IBRX) shares rose nearly 1% overnight heading into Tuesday after CNBC host Jim Cramer called it a “very good spec,” citing a wave of biotech acquisitions as the…

Leer el artículo completo en Stocktwits Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (stocktwits.com)

IBRX Stock Rises Overnight: Jim Cramer Backs ImmunityBio As A ‘Very Good Spec’ Amid Biotech Takeover Wave

También te puede interesar

Watsco GAAP EPS of $3.77 misses by $0.32, revenue of $2.22B beats by $10M

AI debt trouble could help Fed’s Warsh get his way with fewer rate hikes

Spotify Technology (NYSE:SPOT) Cut to "Moderate Buy" at Phillip Securities

Breakfast News: Delivery King Eyes Grocery Carts

Best Stocks Under $5

BTIG raises CareDx stock price target to $81 on revenue outlook

IBRX Stock Rises Overnight: Jim Cramer Backs ImmunityBio As A ‘Very Good Spec’ Amid Biotech Takeover Wave

Compartir

También te puede interesar

Watsco GAAP EPS of $3.77 misses by $0.32, revenue of $2.22B beats by $10M

AI debt trouble could help Fed’s Warsh get his way with fewer rate hikes

Spotify Technology (NYSE:SPOT) Cut to "Moderate Buy" at Phillip Securities

Breakfast News: Delivery King Eyes Grocery Carts

Best Stocks Under $5

BTIG raises CareDx stock price target to $81 on revenue outlook